NextPlat Q2 revenue rises on E-commerce demand
NextPlat Q2 revenue rises on E-commerce demand
Overview
US healthcare and technology provider's Q2 revenue grew 21% sequentially, driven by contracted pharmacy and e-commerce
Net loss for Q2 fell 87% yr/yr to $144,000, with gross margin reaching a record 40%
Company attributes improved results to higher-margin 340B pharmacy services and strong e-commerce demand
Outlook
Company expects higher-margin 340B contracted services revenue to increase in coming quarters
NextPlat anticipates sustainable positive operating income for the remainder of 2026
Company expects new customer contracts to increase revenue in Q3, with more impact in early Q4
Result Drivers
340B CONTRACTED PHARMACY GROWTH - Co said higher-margin 340B contracted pharmacy services prescription volumes grew over 33% yr/yr, supported by new client signings and business development
E-COMMERCE DEMAND - Sequential e-commerce revenue rose 27%, driven by global demand for satellite-based IoT and Push-to-Talk hardware, especially from government and military customers
GROSS MARGIN IMPROVEMENT - Healthcare segment gross margin rose to 46%, attributed to new contracted medication fulfillment services and lower drug acquisition costs from Medicare Drug Price Negotiation Program
Company press release: ID:nPnbr3RPxa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $11.88 mln | $11 mln (1 Analyst) |
Q2 Loss Per Share |
| $0.05 |
|
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the wireless telecommunications services peer group is "buy"
Wall Street's median 12-month price target for NextPlat Corp is $12.00, about 78.8% above its August 12 closing price of $6.71
Reuters Recommended Reads
Aug 11 - Cardinal Health forecasts full-year profit above estimates on specialty drug strength
Aug 12 - SKYX Q2 revenue beats estimates on e-commerce, retail expansion
Aug 11 - Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Nextplat
See all newsBrief: Nextplat Completes Pensacola-Area Acquisition Of Profitable Pharmacy, Accelerating Continued Healthcare Growth And Profitability
NextPlat Corp reports results for the quarter ended June 30 - Earnings Summary
NextPlat Q2 revenue rises on E-commerce demand
NextPlat Corp expected to post a loss of 21 cents a share - Earnings Preview
Brief: Nextplat Delivers Mid-Year 2026 Shareholder Update Confirming Strong Growth And Profitability Outlook